Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 52.30 | N/A |
| PEG Ratio (TTM) | -4.45 | N/A |
| P/S Ratio (TTM) | 1.31 | N/A |
| P/B Ratio (TTM) | 7.05 | N/A |
| P/FCF Ratio (TTM) | 16.21 | N/A |
| Price to 5YR AVG Earnings Ratio | 24.32 | N/A |
| Price to 5YR AVG FCF Ratio | 29.96 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.83% | N/A |
| ROE (TTM) | 13.05% | N/A |
| Net Profit Margin (TTM) | 2.49% | N/A |
| ROIC 5YR AVG | 30.63% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3,149.88% | 19.91% | 5.68% |
| Revenue | 0.13% | 60.43% | 43.84% |
| Net Income | 3,000.09% | 27.82% | 8.04% |
| Cash Flow | 95.52% | 209.83% | 151.29% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.94 | N/A |
| Quick Ratio (TTM) | 3.15 | N/A |
| D/E Ratio (TTM) | 1.75 | N/A |
| Interest Coverage (TTM) | 4.15 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 4.34 | N/A |
| LTL to 5YR AVG FCF | 8.56 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.21% | N/A |